Supporting the Body’s Natural Healing Process
The First FDA-Cleared Liquid Extracellular Matrix (ECM) for Advanced Wound Care
Real Patient Outcomes
Designed for topical application to surgical wounds, post-Mohs surgery, burns, traumatic wounds, donor sites and grafts, diabetic foot ulcers, venous leg ulcers, pressure injuries, skin tears, and other acute and chronic wounds.
Built on Decades of Experience
For more than 25 years, Clay Fette, a regenerative medicine tissue engineer, and Danielle Fette, a wound care nurse, have dedicated their careers to advancing extracellular matrix technology and improving patient care.
After seeing the impact of their Multi-Tissue Platform (MTP®) in hospitals, they developed ReyaGel to bring that same technology to a broader range of clinical applications.
Our MTP Technology in the news.
Why Liquid ECM Matters
Traditional extracellular matrix products are often available in sheets or powders.
ReyaGel’s liquid format allows ReyaGel to conform to complex tissue surfaces where powders and sheets may be difficult to apply, expanding the potential applications of extracellular matrix technology.
We Knew More Was Possible.
So we Built it Our Way
Tissue Engineer
Wound Care Nurse
Clinically Proven
MTP technology has been used on hundreds of thousands of patients in hospitals.
Naturally Derived
Hundreds of biomolecules naturally found within the extracellular matrix
FDA- Cleared Innovation
The first liquid ECM of its kind.